Sort
51,593 grants matching “hepatitis”
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
$732,050Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U24 · FY2024 · HL
Adenovirus Protease Regulation and Antiviral Development
$732,035Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2005 · AI
Universal HCV screening in pregnancy: Examining testing uptake and HCV care
$731,960Shashi Kapadia · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · DA
The Progression of Hepatitis C Among IDUs
$731,929David L Thomas · Johns Hopkins University · R01 · FY2009 · DA
Repurposing Siponimod for Alzheimer's Disease
$731,856Marwan Noel Sabbagh · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · AG
ESTABLISHMENT OF A BREEDING AND RESEARCH PROGRAM
$731,476Coulston Foundation · U42 · FY2000 · RR
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women
$731,445Andrea A. Kovacs · University Of Southern California · R01 · FY2017 · DA
Mechanisms for regulation of a novel class of anti-diabetic lipids
$731,406Barbara B Kahn · Beth Israel Deaconess Medical Center · R01 · FY2024 · DK
Blood Donor Competence, Autonomy and Relatedness Enhancement (Blood Donor CARE)
$731,352Christopher R France · Ohio University Athens · R01 · FY2017 · HL
Risk Factors for AIDS Among Intravenous Drug Users
$731,345Beth Israel Medical Ctr (New York) · R01 · FY2004 · DA
Physiologic Consequence of Genetic Variation
$731,183Richard M Watanabe · University Of Southern California · R01 · FY2020 · DK
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis
$731,052Gaya K. Amarasinghe · Washington University · R01 · FY2025 · AI
Mechanisms of viral proteases in coronavirus replication and pathogenesis
$730,847Susan C. Baker · Loyola University Chicago · R01 · FY2017 · AI
Epidemiology of Oncogenic Viruses
$730,797Thomas R O'Brien · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Vascular delivery of nanocarriers by erythrocyres
$730,596Vladimir R Muzykantov · University Of Pennsylvania · R01 · FY2018 · HL
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$730,528Marc R Montminy · Salk Institute For Biological Studies · R37 · FY2017 · DK
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$730,528Marc R Montminy · Salk Institute For Biological Studies · R37 · FY2016 · DK
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$730,528Marc R Montminy · Salk Institute For Biological Studies · R37 · FY2015 · DK
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 Pathway
$730,528Marc R Montminy · Salk Institute For Biological Studies · R37 · FY2018 · DK
Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals with Obesity
$730,498Jean-Marc Schwarz · Touro University Of California · R01 · FY2025 · DK
Targeting the gut-liver axis in cardiovascular disease
$730,352Thomas A Vallim · University Of California Los Angeles · R01 · FY2024 · HL
Identification of Allsoteric Ligands for Hepatic Nuclear Factor 4-alpha
$730,351Fraydoon Rastinejad · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · DK
Discovering Small Molecule Biased Agonists for the Neuropeptide S Receptor
$730,330Scott P Runyon · Research Triangle Institute · R01 · FY2022 · MH
HBV cccDNA transcriptional silencing with and without HIV
$730,270Ashwin Balagopal · Johns Hopkins University · R01 · FY2024 · AI
Intensive Models of HCV Care for Injection Drug Users
$730,134Alain Litwin · Albert Einstein College Of Medicine · R01 · FY2014 · DA